eTheRNA Immunotherapies NV: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences' Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA

Financing round led by Novalis LifeSciences LLCBoth investors Dr. Marijn Dekkers and Moderna's co-founder Dr. Kenneth Chien to join the board of directorsStrategic focus includes customized lipid nanoparticles

Related Keywords

Sweden ,Stockholm ,Belgium ,Swedish ,Steven Powell ,Russell Greig ,Kostenloser Wertpapierhandel ,Kenneth Chien ,John Fraunces ,Bernard Sagaert ,Novalis Lifesciences ,Bayer Ag ,Professor Of The Swedish Research Council ,Lifesci Advisors ,Karolinska Institute ,Company Contact ,Thermo Fisher Scientific Inc ,Life Sciences ,Omega Fund ,Marijn Dekkers ,Professor Kenneth Chien ,Grand Pharma ,Moderna Therapeutics ,Distinguished Professor ,Swedish Research Council ,Life Science ,Sci Advisors ,Etherna ,Mmunotherapies ,Rna ,Reading ,Expert ,Kenneth ,Tchien ,Inovalis ,Lifesciences ,Karijn ,Bekkers ,Investing ,Series ,Financing ,Technology ,Platform ,Company ,